Special Authority requests for mepolizumab

OIA response

Thank you for your request dated 10 July 2023 under the Official Information Act 1982 (OIA) for information relating to mepolizumab. You requested:

could you please provide the same data for the new SA number for mepolizumab that changed in August 2022: SA2154 – mepolizumab 

the number of initial and renewal applications approved by month from August 2022 to the most recent available month for Severe Eosinophilic Asthma or Severe Asthma. 

We are pleased to provide you with the data you requested in the excel document attached.

We trust that this information answers your queries. Please note, you have the right to make a complaint to the Ombudsman about our response to your OIA, under section 28(3) of the OIA. Details of how to make a complaint(external link) are on the Ombudsman’s website.

To make information more freely available, we publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.